Recurrence and Circulating Tumor DNA in Human Papillomavirus-Positive Oropharyngeal Cancer: A Meta-Analysis.
Blood tests for cancer DNA reliably detect early recurrence in throat cancer survivors, enabling faster intervention when caught before symptoms appear.
This systematic review and meta-analysis synthesizes evidence on ctDNA as a surveillance biomarker in HPV-positive oropharyngeal cancer, demonstrating high sensitivity for early recurrence detection. The pooled data support integration of ctDNA surveillance into post-treatment protocols to enable earlier salvage intervention.
What the study was
- Study design
- Systematic review and meta-analysis
- Population
- HPV-positive oropharyngeal cancer patients post-treatment
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Why it surfaced
Meta-analysis supporting ctDNA as a near-implementable surveillance biomarker in HPV+ oropharyngeal cancer; early recurrence detection has direct treatment intervention implications.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.